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discrimination Learning, Reversal, and Set-Shifting in
irst-Episode Schizophrenia: Stability Over Six Years
nd Specific Associations withMedication Type and
isorganization Syndrome
erity C. Leeson, Trevor W. Robbins, Elizabeth Matheson, Samuel B. Hutton, María A. Ron,
homas R.E. Barnes, and Eileen M. Joyce
ackground: The intradimensional/extradimensional (IDED) task assesses different forms of learning from feedback. Limited evidence
uggests that attentional set-shifting deteriorates over time in schizophrenia. We tested this hypothesis and examined the specificity of
earning impairments identified by this task.
ethod: Twohundred sixty-twofirst-episodepatients and76healthy control subjects,matched for ageandpremorbid IQ,were tested; 104
atients and 25 control subjects were reassessed 1 and 3 years later, and 31 patients were reassessed additionally 6 years later.
esults: Patients showed impaired set-shifting that correlatedwith current IQ andworkingmemory, but therewere no impairments when
ubgroups werematched on current IQ. In contrast, patients showedmarked impairments in rule reversal learning that survived correction
or IQ, were present in the context of intact rule abstraction, and correlated with disorganization symptoms. Patients prescribed second-
eneration antipsychotics were worse on set-shifting comparedwith first-generation, a finding not explained by demographic data, illness
haracteristics, or IQ. Patients and control subjects showed stable IDEDperformanceover thefirst 6 years of illness, although set-shiftingwas
nconsistent over the first year. Those with residual negative symptoms were more likely to fail the set-shifting stage at follow-up.
onclusions: First-episode schizophrenia patients can learn and generalize rules but are inflexible when rules change, reflecting reduced
esponsiveness to negative feedback and difficulty in switching attention. Rule-reversal is a promising target for translational studies,
ecause it is specific, clinically relevant, and might reflect orbitofrontal dysfunction. Set-shifting is related to poor function more generally
ut might be sensitive to medication effects and valuable for clinical trials.ey Words: Cognition, first-episode, IDED, reversal learning,
chizophrenia, set-shifting
eing able to learn by experience is crucial for effective
negotiation of the environment. Patients with schizophre-
nia show learning impairments on episodic memory tasks
1), but less is known about how learning is shaped by positive
nd negative feedback (2). This is relevant, because recent
odels of experience-dependent learning implicate cognitive
nd neural substrates considered dysfunctional in schizophrenia.
or example, the dopaminergic input to striatum and prefrontal
ortex is thought to signal unexpected events and facilitate a shift
n attention to promote new learning (3), and prefrontal atten-
ional processes have been shown to selectively “tune” into
ask-relevant stimuli during learning (4).
The Cambridge Neuropsychological Test Automated Battery
CANTAB) intradimensional/extradimensional (IDED) task (5,6)
ends itself to the study of learning in schizophrenia, because
ubjects progress through different stages in which responses
an be modified by feedback. As well as discrimination learning,
ther types of learning important for adapting to a changing
nvironment can be measured. These include learning to change
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oi:10.1016/j.biopsych.2009.05.016responses when stimuli are no longer relevant (reversal learn-
ing), learning to generalize responses from a particular stimulus
to others in the same category or dimension (rule abstraction),
and shifting attention to a different stimulus dimension when the
current dimension is no longer fruitful (attentional set-shifting).
Studies of this task in nonhuman primates and man have shown
that these different forms of learning are mediated by different
neural processes (6). For example, a double-dissociation has
been demonstrated implicating lateral prefrontal cortex in atten-
tional set-shifting and orbitofrontal cortex in reversal learning
(7–10), and dopamine innervation of prefrontal cortex seems to
“stabilize” attentional-set and promote rule learning (11,12).
Previous studies of schizophrenia have found different pat-
terns of deficit in first-episode patients compared with those with
long-standing illness. Most first-episode patients pass the test,
with the remainder failing at the attentional set-shifting stage
(13,14). Patients with longer illness durations are more impaired,
mainly in set-shifting but also at earlier stages (15–19). Some
studies (20,21) but not all (17,19,22) have found an inverse
relationship between illness duration and set-shifting ability, and
there are preliminary reports of deterioration in performance 1
year or 7 years after the first episode (23,24). Ceaser et al. (19)
recently found that, in contrast to schizophrenia patients, their
healthy siblings were only minimally impaired on the task,
suggesting that IDED performance is not an intermediate phe-
notype of the genetic risk for schizophrenia (19) but might be
sensitive to illness processes that deteriorate over time after
illness onset. Because there are few controlled longitudinal
studies of specific cognitive functions after the first episode (25),
a finding of deterioration in IDED performance would be of
clinical importance by providing a target for future pharmaco-
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V.C. Leeson et al. BIOL PSYCHIATRY 2009;66:586–593 587ogical remediation (26). In the current study, we tested this
ypothesis by assessing IDED performance in schizophrenia
atients at first episode and again 1 year and 3 and 6 years after
nset and compared this with healthy control subjects tested at
he same time points. On the basis of previous studies we
redicted that set-shifting performance would deteriorate over
ime.
Also, of relevance is whether the IDED task identifies specific
orms of learning impairment. For example, the studies of
ong-standing schizophrenia that have examined current IQ
ffects on IDED have reached different conclusions about the
pecificity of set-shifting (15,16,18,19), and no study has exam-
ned this at first-episode. Cognitive Neuroscience Treatment
esearch to Improve Cognition in Schizophrenia (CNTRICS) has
ecently recommended IDED as a task-measuring rule genera-
ion and selection for possible translation into clinical trials,
artly on the basis of its widespread use in animal behavioral
harmacology (25). Thus, determining the specificity of any
earning impairment is important, especially at first episode
hen remediation strategies are likely to be most effective. We
herefore assessed the impact of generalized cognitive function-
ng on performance at the different stages of the task by
easuring premorbid and current IQ and also examined the
elationship between IDED performance and working memory.
o test the clinical relevance of our findings, we examined
erformance variables in relation to symptoms and social func-
ion and compared the effect of first- and second-generation
edication.
ethods andMaterials
articipants
Patients were recruited in their first psychotic episode and
ad 12 weeks antipsychotic medication exposure; 262 individ-
als with a diagnosis of schizophrenia (n  235), schizophreni-
orm (n  3), or schizoaffective disorder (n  24) were included
see [27] for more details). The baseline data of 136 patients were
eported previously (20). The control group comprised 76
ealthy volunteers, recruited from local job centers, schools, and
ospitals, without a prior history of psychiatric illness in them-
elves or first-degree relatives, head injury, neurological or
ndocrine disorder, or drug or alcohol dependence. Research
thics Committee permission was obtained. Participants gave
ritten informed consent and were paid an honorarium for their
ime. One hundred four patients and 25 control subjects were
eassessed twice; mean weeks to second and third assessments:
atients  65.33 (34.77) and 177.91 (77.66), respectively; control
ubjects  60.48 (33.37) and 129.75 (44.08), respectively.
linical Assessments
Psychotic symptoms were assessed with the Scales for the
ssessment of Positive and Negative Symptoms (28,29), and
cores for the three syndromes of schizophrenia (30) were
alculated. Social function was assessed with the Social Function
cale (31). Duration of untreated psychosis (DUP) was calculated
s the time from onset of psychotic symptoms to first treatment
ith antipsychotic medication (32).
europsychological Assessment
For the IDED task, subjects learn a series of visual discrimi-
ations in which one of two stimuli is correct. Feedback from the
omputer indicates whether a choice is correct (green tick, high
one) or incorrect (red cross, low tone). The rule is changed after
ix consecutive correct choices. If the learning criterion is notachieved within 50 trials, the test is discontinued. Stage 1 (simple
discrimination [SD]) requires learning of the correct stimulus
from a choice of two shapes; at Stage 2 (simple reversal [SR]) the
previously irrelevant shape becomes correct. At Stage 3 (com-
pound discrimination [C_D]) a second dimension (line) is intro-
duced alongside the shape dimension with each of the two
stimuli containing a shape and line; subjects need to continue
selecting the shape dimension. At Stage 4 (compound discrimi-
nation [CD]), the lines are superimposed onto shapes in each
stimulus, and responding to the previous shape is required. At
Stage 5 (compound reversal [CR]) the previously incorrect shape
now becomes the correct response. Thus, at stages 1–5, the
exemplars are the same, and subjects are required to respond to
the same dimension of shape. Stage 6 (intradimensional shift
[IDS]) tests the veracity of rule learning as new compound line
and shape exemplars are introduced, but the same dimension
(shape) remains correct. Selection of the previously incorrect
shape pattern is required at Stage 7 (intradimensional reversal
[IDR]). Stage 8 tests attentional set-shifting (extradimensional
shift [EDS]) as the previously irrelevant dimension (line) now
becomes relevant, and one of the line patterns becomes the
correct response. At Stage 9 (extradimensional reversal [EDR])
the previously incorrect line becomes the required response. The
various stages of this task require simple discrimination learning,
compound discrimination learning, abstraction, attentional set-
shifting, and reversal learning.
Other CANTAB executive tasks were employed for compari-
son. Working memory manipulation was measured with the
Spatial Working Memory task, whereby participants need to
recall where previous “tokens” were found from a random array
of “boxes” to maximize success at finding subsequent “tokens”.
The number of search errors was measured. Working memory
span was measured with a version of the Corsi block test,
requiring the recall of consecutively presented boxes at different
spatial locations. Premorbid IQ was estimated with the National
Adult Reading Test (NART-R) (33). Current IQ was calculated
from four subtests of the Wechsler Adult Intelligence Scale-
Revised (34) or Wechsler Adult Intelligence Scale-III (35), which
have been shown to provide reliable measures of full-scale IQ in
psychosis (36,37).
Analyses
Univariate analysis of variance (ANOVA) was used for demo-
graphic data and linear neuropsychological measures. Task
analyses included only patients attempting a given stage; num-
bers passing were analyzed with 2 tests and pass rates for each
stage with likelihood ratio analysis (38). Errors were not normally
distributed and could not be normalized by mathematical trans-
formation and thus were compared with Kruskal–Wallis compar-
isons. For repeated measures, errors were analyzed with Fried-
man’s ANOVA and pass rates with Cochran’s Q. Correlations
among errors, symptoms, and social function were analyzed with
Spearman’s . Logistic regression was employed to determine
measures that predicted passing the test.
Results
Demographic Data
There were no statistically significant differences between the
baseline groups on age or premorbid IQ (Table 1); there were
more women in the control group. Followed-up subjects did not
differ significantly on any variable.
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waseline Performance
Pass/Fail. More control subjects than patients completed all
ine stages (2  9.32, p  .002) (Figure 1). Significantly more
atients failed at the EDS stage (2i  6.80, p  .009) but not at any
ther stage (all p values  .1). Patients made significantly more
rrors on the first two learning stages, SD and C_D, but not at later
D and IDS stages; they also made more errors at the EDS stage.
atients made significantly more errors at every reversal stage; even
hose patients passing EDS subsequently made more errors at EDR.
Correlations. When we examined only those patients reach-
ng the EDS stage (n  242), errors at EDS did not correlate with
rrors at the SD (  .01, p .881) or C_D (  .06, p .345)
tages or the summed errors from reversal stages before EDS
  .01, p  .957). The EDS errors correlated with current IQ
r.40, p .001), working memory span (r.23, p .001),
nd working memory manipulation (r  .23, p  .001), so that
etter ability was related to fewer errors.
IQ Effects. Current IQ was lower in patients (mean [standard
eviation] IQ, patients [n  236]: 88.17 [16.54]; control subjects:
00.93 [12.69]) [F (1,311)  38.04, p  .001]. We therefore
xamined matched groups with a current IQ in the average range
r above (IQ  90; patients n  98, mean 103.82 [11.58]; control
ubjects n  63, mean 104.60 [10.52]) [F (1,160)  .19, p 
able 1. Demographic Data for Patients and Control Subjects Completing
ssessments
Initial Assessment
Patients Control Subjects Com
262 76
ender 189 M/73 F 40 M/36 F 2 10.26,
ge in Yrs 25.74 (7.90) 26.42 (7.63) F(1,337) .
remorbid IQ (NART) 95.78 (13.44) 98.74 (10.76) F(1,323) 3
National Adult Reading Test (NART) not completed in 14 patients.ww.sobp.org/journal.663]. The overall pass rate in this subset was higher for both
groups (patients: 73.5% vs. 58.4%; control subjects: 84.1% vs.
77.6%), which was not different (2  2.51, p  .113). Both
groups passed SD, SR, CD, and CR; and there were no pass/fail
differences at other stages (all p  .1) including EDS (2i  1.44,
p .231). Increased reversal errors in patients were evident at CR
(2  5.47, p  .017), IDR (2  5.07, p  .024), and EDR (2 
3.31, p  .069).
Clinical Relationships. The strongest finding was that rever-
sal errors correlated significantly with disorganization syndrome
at every stage, particularly with respect to positive formal
thought disorder (e.g., SR stage:   .21, p  .001) (Table 2).
There were no differences between those passing or failing EDS
on social function [F (1,223)  2.75, p  .100] or negative
[F (1,240)  1.52, p  .219], positive [F (1,240)  .01, p  .981],
and disorganization [F (1,240)  .49, p  .486] syndromes.
Medication Effects. Fourteen were drug-free, 61 were pre-
scribed first-generation antipsychotics (haloperidol n  15;
sulpiride n  23; droperidol n  9; trifluoperazine n  10;
thioridazine n  2; chlorpromazine n  1; flupentixol n  1),
and 172 were prescribed second-generation antipsychotics (ris-
peridone n  55; olanzapine n  102; amisulpride n  8;
quetiapine n  3; clozapine n  1; aripiprazole n  3); 15 were
europsychological Assessment and the Subgroups Completing all Three
Three Assessments
n Patients Control Subjects Comparison
104 25
001 72 M/32 F 13 M/12 F 2 2.66, p .103
 .506 26.02 (8.09) 26.92 (7.66) F(1,128) .26, p .615
 .080 98.98 (12.50) 97.83 (11.24) F(1,218) 1.4, p .113
Figure 1. Baseline attentional set shifting task perfor-
mance. Upper panel: for patients and control subjects,
mean errors with standard error bars are shown on the y
axis for each stage denoted along the x axis. For each
stage, Kruskal–Wallis comparisons aregiven. Lowerpanel:
on the left the cumulative pass rate (%) is given on the y
axis for each stage denoted along the x axis. For each
stage this refers to the total number of patients and con-
trol subjects who have passed up until and including the
current stage. On the right, the pass rate for the individual
stage (%) is given on the x axis for each stage denoted on
the y axis. This refers to the number of patients and con-
trol subjectswhoactually attempted thatparticular stage,
having passed the previous stage. SD, simple discrimina-
tion; SR, simple reversal; C_D, compound discrimination;
CD, compound discrimination; CR, compound reversal; IDS,
intradimensional shift; IDR, intradimensional reversal; EDS,
extradimensional shift; EDR, extradimensional reversal.One N
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V.C. Leeson et al. BIOL PSYCHIATRY 2009;66:586–593 589aking a combination and excluded from the analyses. Sixty-four
ercent of the drug-free group, 74% of the first-generation
ntipsychotic group, and 52% of the second-generation antipsy-
hotic group passed all stages of the test, and this difference was
ignificant (2  8.74, p  .013). Pairwise analyses revealed that
ore patients prescribed first-generation passed the task com-
ared with those prescribed second-generation antipsychotics
2  8.50, p  .004). Stage-by-stage analysis showed that only
assing at EDS stage was different between groups (2  9.12,
 .010; all other stages p  .1). There were no differences
etween those taking first- and second-generation antipsychotics
n any clinical or cognitive variable that might mediate this
ifference (Supplement 1). There were no differences between
roups prescribed anticholinergics (n  52) or not (n  210) on
assing the task (2  .55, p  .457).
hange Over 1 Year and 3 Years
Pass/Fail. The number of patients passing the entire task
hanged over time (baseline 63.5%, 1-year 52.9%, 3-year 72.1%;Q
0.75, p .005), reflecting a trend for deterioration from baseline to
year (Q 3.67, p .056), but no difference between baseline and
years (Q 1.98, p .160) (Figure 2, Table 3). The control subjects
id not show significant change over time (baseline 88%, 1 year
8%, 3-year 96%; Q  2.67, p  .264).
The patients showed a significant change over time in passing
DS (baseline: 70.8%, 1-year: 59.6%, 3-year: 75.3%; Q 6.78, p
034), reflecting significant decline from baseline to 1-year (Q 
able 2. Spearman’s Correlations Between Errors at Each Stage and Clinica
tage SD SR C_D
egative Syndrome .12 .15a .06
ositive Syndrome .08 .12 .01
isorganization Syndrome .03 .21c .13a
ocial Function .05 .10 .17b
SD, simple discrimination; SR, simple reversal; C_D, compound discrimi
ional shift; IDR, intradimensional reversal; EDS, extradimensional shift; EDR
ap .05.
bp .01.
cp .001.
igure 2. The upper panel shows cumulative pass rates for patients and con
ho completed all three assessments. This denotes the percentage of sub
umber of errors committed at each stage at the three time points for patients a4.48, p  .034), but no difference between baseline and three
years (Q  1.60, p  .206). The control subjects did not change
over time (baseline: 92%, 1-year: 96%, 3-year: 100%; Q  2.00,
p  .368). There was no significant change in pass rate at other
stages (patients: all p .1 except IDS: Q 5.20, p .074; control
subjects: all stages passed except EDR: Q  3.00, p  .223).
Passing the test at the first assessment predicted passing at the
second assessment in patients (2  14.08, p  .001, Wald 
12.91, exp[]  .204) and control subjects (2  6.39, p  .011,
Wald  5.48, exp[]  .024).
Errors. Friedman’s ANOVA showed that the patients did not
change significantly in the number of errors made at any stage
(all p  .1).
Clinical Relationships. When patients passing and failing
EDS at the second assessment were compared on concurrent
clinical features, there were no differences in social function
[F (1,98)  .13, p  .716] and the presence of positive (2  .71,
p  .400) or disorganization (2  .38, p  .536) symptoms.
Significantly more patients failing EDS had residual negative
symptoms (2  6.91, p  .001). This pattern was similar at the
third assessment [social function: F (1,99)  .01, p  .989;
negative syndrome: 2 4.88, p .027; positive syndrome: 2
.63, p  .428; disorganization syndrome: 2  1.35, p  .245].
Six-Year Follow-Up
Thirty-one patients received a further assessment a mean of
322.26 (91.08) weeks after their first assessment (Figure 3). They
sures
CD CR IDS IDR EDS EDR
.08 .01 .01 .06 .06 .06
.08 .08 .03 .02 .09 .12
.00 .14a .06 .14a .04 .15a
.07 .15a .00 .11 .02 .01
n; CD, compound discrimination; CR, compound reversal; IDS, intradimen-
adimensional reversal.
bjects at baseline, 1 year follow-up, and 3-year follow-up for those subjects
passing up to and including the current stage. The lower panel shows thel Mea

natio
, extrtrol su
jectsnd control subjects. Abbreviations as in Figure 1.
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wad a mean age of 25.10 (7.93) years at baseline and mean NART
Q of 99.87 (12.21), comprised 25 men and 6 women, and did not
iffer from remainder of patients in the larger followed-up group
premorbid IQ: F (1,103) .22, p .637; age: F (1,103) .57, p
452; gender: 2 2.71, p .100]. There was a trend for a change
ver time in overall pass rate (Q  6.58, p  .087). Post hoc
nalysis showed that more patients failed at 1 year than baseline
Q  6.40, p  .01), but there were no differences between
aseline and three years (Q  2.57, p  .11) or baseline and 6
ears (Q  .50, p  .48). There were no differences in pass rate
t EDS (Q  3.78, p  .286) or any other stage (all p  .1) over
ime or in the number of errors made at any stage over time
xcept SR (2  8.08, p  .044; all other stages p  .1).
iscussion
In this study of first-episode schizophrenia, we used a single
ask to examine cognitive processes essential for successful
daptation to a changing environment. These were discrimina-
ion learning and reversal, rule abstraction, and set-shifting (5,6).
here were several major findings in addition to confirming the
ell-established impairment in set-shifting (39,40). First, schizo-
hrenia patients showed a marked impairment in reversal learn-
ng that was present in the context of intact rule abstraction and
as linked to disorganization symptoms. Second, set shifting was
oorer in those patients prescribed second-generation than
irst-generation antipsychotic medication. Third, performance
eemed stable when tested over a period of 6 years from illness
nset.
Patients showed the most pronounced deficit at the atten-
ional set-shifting stage (EDS) of the task, when they were
equired to inhibit their current responding to a stimulus dimen-
ion and learn to respond to a different dimension. This is also
he most common finding in previous studies of first-episode or
ong-standing schizophrenia (14–16,18,19,40). Performance of
DS entails several cognitive processes including shifting the
ocus of attention and learning from feedback. In a positron
mission tomography study, Rogers et al. (8) found that the
orsolateral prefrontal cortex (DLPFC) was more active during
DS than during performance at the rule abstraction stage (IDS).
ampshire and Owen (9) examined EDS with a functional
agnetic resonance imaging task in which the subjects repeat-
dly shifted attention between stimulus dimensions, thus disam-
iguating the attentional shift from learning how to solve the
roblem. They found that ventrolateral prefrontal cortex (VLPFC)
as specifically active during the attentional shift, whereas
able 3. Errors (Standard Deviation) at Each Stage over the Three Assessm
ith Separate Repeated Measures Analyses (Friedman’s ANOVA) for Patient
Patients
Baseline 1 Yr Three-Yr Compa
D .95 (1.19) 1.01 (1.62) 1.15 (1.68) 2 3.02, p
R 1.72 (2.56) 1.40 (1.12) 1.77 (3.34) 2 1.64, p
_D 1.58 (3.32) 1.82 (4.45) 1.88 (4.15) 2 .34, p
D .75 (2.74) .69 (3.46) .88 (4.10) 2 1.68, p
R 1.81 (2.60) 2.16 (3.82) 2.57 (4.68) 2 .91, p
DS 1.93 (5.14) 1.45 (4.46) 1.53 (4.78) 2 .77, p
DR 2.90 (5.72) 2.44 (5.06) 2.44 (5.08) 2 1.16, p
DS 13.00 (9.93) 13.82 (10.87) 11.42 (10.02) 2 1.78, p
DR 11.05 (11.21) 12.48 (11.69) 9.13 (10.69) 2 3.02, p
ANOVA, analysis of variance; other abbreviations as in Table 2.LPFC activity reflected more the strategic and working memory
ww.sobp.org/journaldemands involved in the EDS problem solution. This finding
informs the interpretation of our findings, because EDS errors
correlated significantly with current IQ and independent mea-
sures of working memory but not with within-task measures of
discrimination learning and reversal. Furthermore, when we
examined subgroups of patients and control subjects matched for
current IQ, there were no EDS pass/fail differences. This suggests
that the EDS impairment in schizophrenia reflects the general
problem-solving requirements of this stage, a conclusion sup-
ported by a large-scale study of long-standing schizophrenia
showing pronounced IQ effects on EDS performance (20) and
compatible with the well-established DLPFC deficits in this
patient group (41). Our finding that failing EDS, when retested at
1 year and 3 years, was related to the presence of enduring
negative symptoms also supports the contention that EDS is
sensitive to generally poor function in patients with schizophre-
nia.
In contrast, the patients had striking difficulty with reversal
learning, which survived correction for current IQ. They made
more errors than control subjects at every reversal stage at
baseline, and this pattern persisted when tested on two subse-
Figure 3. Cumulative pass rates by stage at baseline, 1 year, 3-year, and
6-year follow-up assessments in the subset of patients who had completed
all four assessments (n 31). This denotes the% subjects passing up to and
n Patients and Control Subjects that Completed all Three Assessments
Control Subjects
Control Subjects
Baseline 1 Yr Three-Yr Comparison
21 .56 (.65) .68 (.80) .72 (1.49) 2 .84, p .656
39 1.20 (.65) 1.24 (.52) 1.32 (.63) 2 1.65, p .439
3 .48 (.71) .84 (2.01) .56 (1.26) 2 .78, p .679
32 .20 (.58) .08 (.28) .04 (.20) 2 1.20, p .549
4 1.12 (.33) 1.48 (1.05) 1.52 (.77) 2 5.88, p .053
2 .52 (1.29) .60 (.76) .76 (1.50) 2 4.98, p .083
61 1.08 (.28) 1.16 (.80) 1.20 (.65) 2 .50, p .779
10 6.80 (7.20) 6.12 (6.15) 3.80 (4.15) 2 5.28, p .071
21 4.52 (7.97) 4.00 (7.93) 2.32 (4.76) 2 1.22, p .544ents i
s and
rison
 .2
 .4
 .84
 .4
 .63
 .68
 .5
 .4
 .2including the current stage. Abbreviations as in Figure 1.
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V.C. Leeson et al. BIOL PSYCHIATRY 2009;66:586–593 591uent occasions over 3 years. Our findings are compatible with
study (39) that used a task analogous to the SD and SR stages
n the attentional set-shifting task but with probabilistic contin-
encies; patients acquired the discrimination but were impaired
n reversal. In addition, Murray et al. (14) found that those
atients who attempted all stages of the attentional set-shifting
ask made more total reversal errors than control subjects. When
e compared subgroups matched on current IQ, reversal learn-
ng was still impaired, with patients making more errors on three
f the four reversal stages. Thus, regardless of current intellectual
unction, patients were less able than control subjects to modify
heir behavior in response to negative feedback.
This finding is evidence for dysfunction of orbitofrontal cortex
OFC). Studies have shown that the OFC is involved in the
ontrol of responding in the face of changing reward/punish-
ent contingencies (42,43). The OFC is activated in man and
onhuman primates during reversal learning (44–46), and re-
uced OFC activity is associated with poor reversal learning (47),
upporting the view that this area is active when negative
eedback signals the need to change a response set. Hampshire
nd Owen (9) found that lateral OFC was specifically active
uring an attentional shift after negative feedback rather than
uring the negative feedback itself and suggest this area is
esponsible for implementing a response shift rather than pro-
essing negative feedback. Compatible with this are the findings
rom other studies that suggest that OFC serves to maintain the
epresentation of the negative value of stimuli for action selection
48–50). In our study, the persistent reversal learning deficit
ight be secondary to the diminished ability of patients to
epresent the value of negative feedback. An alternative expla-
ation is that patients learned to ignore the alternate aspects of
he stimulus array. However, Elliott et al. (15) found that patients
ith schizophrenia were impaired on this task, not because of
earned irrelevance but because they perseverated on a previ-
usly reinforced dimension, a finding compatible with an expla-
ation of reduced responsivity to negative feedback. A relevant
tudy (51) showed that patients with schizophrenia had difficulty
n “translating experience into action.” Thus, compared with
ontrol subjects, patients described similar depths of emotion to
ositive, negative, and neutral stimuli but acted as if the stimuli
ere less emotionally arousing, and this was particularly evident
or stimuli with negative valence. This might also explain our
revious findings with a gambling task sensitive to OFC function
42). Patients with first-episode schizophrenia were able to judge
orrectly the magnitude of rewards/punishments that varied over
rials but were less able than control subjects to act on this
nformation by adjusting how many points they “bet” on any one
rial (52). Similarly, Heerey et al. (53) found that patients with
chizophrenia made suboptimal decisions, especially concerning
otential losses on their gambling task.
We found a significant correlation between reversal errors at
very stage and the disorganization syndrome, particularly the
ormal thought disorder (FTD) component. Although the size of
he correlations was small, other findings suggest that this link
ight be important. A meta-analysis found that, of all cognitive
mpairments associated with FTD, one of the strongest was
xecutive inhibition (54). Our findings shed light on the speci-
icity of this association, because disorganization did not corre-
ate with other aspects of IDED performance. Thus, FTD might
eflect a difficulty in inhibiting a previous response or thinking
attern rather than an inability to shift attention and respond
ppropriately. It is also noteworthy that a neuroimaging study of
chizophrenia found that reduced volume of OFC was associatedwith increased FTD (55). Tentatively, these findings suggest that
reversal deficits in schizophrenia might be a clinically promising
target for future remediation, because they are linked not only to
a specific neural process but also to a clinical syndrome.
The patients also made more errors at the first two discrimi-
nation learning stages (SD and C_D) but not at later learning
stages involving compound discrimination and rule abstraction.
Thus, they had initial difficulty in forming an attentional set, but
once acquired, they were able to apply successfully the rule
governing responding to other situations even though the stimuli
were more complex or changed in their physical attributes. This
pattern of responding was the same when retested 1 year and 3
years later. Previous studies of schizophrenia have suggested that
this instability of initial learning reflects dopamine dysregulation
(14,18). A study in the marmoset has shown that prefrontal
dopamine depletion impairs the ability to acquire an attentional
set particularly at the rule abstraction stage (IDS) (12). Because
patients were medicated in these studies and medication, if
anything, tends to improve executive function, it is possible that
intact rule abstraction represented a positive medication effect on
learning.
Those taking second-generation antipsychotics, compared
with first-generation antipsychotics, failed the task more fre-
quently due to impaired EDS performance. Because we could
not identify any other differences between the groups that might
mediate this finding, it suggests that more selective dopamine D2
receptor blockers had a beneficial effect on set-shifting, possibly
by stabilizing dopamine activity in frontostriatal circuitry. In the
absence of a randomized clinical trial, these results must be
regarded tentatively, especially because we could not establish
whether this effect persisted because most patients taking first-
generation antipsychotics had been switched to second-genera-
tion drugs by 1 year follow-up. Furthermore, we did not find this
effect on working memory, another executive function that is
compromised in schizophrenia and thought to be modulated by
forebrain dopamine.
Our prediction of deterioration at the EDS stage was not
borne out when a large group of patients were retested 3 years
after onset. To examine whether our follow-up period might not
have been sufficiently long, we examined a smaller group tested
again at 6 years and found no deterioration. Therefore, we were
unable to replicate a preliminary report of worse performance
over a similar follow-up period and in a similar number of
patients (24). However, we did confirm our own preliminary
finding (23) that fewer patients passed the EDS stage when tested
at 1 year. Thus, a proportion of patients who successfully shifted
set at illness onset failed to do so 1 year later, suggesting that this
cognitive function is unstable in the early stages of the illness. It
is possible that long-term treatment stabilized executive control
over the following years. Alternatively, ceiling effects in control
subjects might have masked a widening gap between patient and
control performance whereby practice counteracted deteriorat-
ing functioning in patients but could not increase success in
control subjects. Against this is that the reduced EDS pass rate at
1 year was not mirrored by changes in error rates at any stage
over three testing sessions.
Taken together our findings suggest that patients with first-
episode schizophrenia can learn and generalize rules but are
inflexible when rules change, reflecting both reduced respon-
siveness to negative feedback and difficulty in switching atten-
tion. This profile seems to represent a stable trait of the illness,
with the proviso that set-shifting seems to fluctuate in the first
year. Given that EDS is also somewhat dependent on working
www.sobp.org/journal
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wemory and general problem solving, our findings suggest that
ttentional set-shifting per se might not be a particularly illumi-
ating construct in schizophrenia. The more rigid and inflexible
ehavior in schizophrenia might be better captured by reversal
earning, because this measure was found to be relatively
ndependent of IQ and associated with a specific clinical syn-
rome at illness onset and has distinct neural substrates. Never-
heless, the finding that EDS was sensitive to medication effects
uggests that it might be a valuable measure in the assessment of
harmacological remediation of cognition in randomized con-
rolled clinical trials.
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